Clinical Trial Alert

Nephrology Times:
doi: 10.1097/01.NEP.0000393760.68365.93
Clinical Trial Alert

    The following is a partial list of new clinical trials recently added to the National Institutes of Health's ClinicalTrials.gov online registry. More information on these trials is available at www.clinicaltrials.gov.

    Back to Top | Article Outline

    • Acute Kidney Disease •

    NCT00791648

    Short-Term Atorvastatin's Effect on Acute Kidney Injury Following Cardiac Surgery

    Ages eligible for study: 18 years and older

    Sponsors and collaborators: Vanderbilt University

    Contact: Frederic T. Billings IV, MD

    Phone: 615-936-8487

    E-mail: frederic.t.billings@vanderbilt.edu

    Back to Top | Article Outline
    NCT00673244

    Protocol to Assess the Severity of Acute Kidney Injury

    Ages eligible for study: 18 years and older

    Sponsors and collaborators: George Washington University

    Contact: Lakhmir S. Chawla, MD

    Phone: 202-715-4570

    E-mail: lchawla@mfa.gwu.edu

    Back to Top | Article Outline
    NCT01209169

    Evaluation of Novel Biomarkers From Acutely Ill Patients at Risk for Acute Kidney Injury

    Ages eligible for study: 21 years and older

    Sponsors and collaborators: Astute Medical Inc.

    Contact: Karin Hughes, PhD

    Phone: 858-882-0466

    E-mail: khughes@astutemedical.com

    Back to Top | Article Outline

    • Anemia •

    NCT01052779

    Ferumoxytol Compared to Iron Sucrose for the Treatment of Iron-Deficiency Anemia in Adult Subjects with Chronic Kidney Disease

    Ages eligible for study: 18 years and older

    Sponsors and collaborators: AMAG Pharmaceuticals Inc.

    Contact: William Strauss, MD

    Phone: 617-498-3300

    E-mail: wstrauss@amagpharma.com

    Back to Top | Article Outline
    NCT00838097

    EU Registry in Pediatric CKD Patients Looking at Safety and Usage Patterns of Darbepoetin Alfa

    Ages eligible for study: Up to 16 years

    Sponsors and collaborators: Amgen

    Contact: Amgen Call Center

    Phone: 866-572-6436

    Back to Top | Article Outline
    NCT00925587

    Study Evaluating Once-Monthly Darbepoetin Alfa Dosing for the Correction of Anemia in Non-Dialysis Patients with Chronic Kidney Disease

    Ages eligible for study: 18 years and older

    Sponsors and collaborators: Amgen

    Contact: Amgen Call Center

    Phone: 866-572-6436

    Back to Top | Article Outline
    NCT01170078

    A Study Comparing the Effects of Epoetin Hospira and Epoetin Alpha (Amgen) When Administered IV in Patients with Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment

    Ages eligible for study: 18 years to 75 years

    Sponsors and collaborators: Hospira Inc.

    Contact: Suzanne K. Swann, MD

    Phone: 612-852-7000

    E-mail: swannx005@umn.edu

    Back to Top | Article Outline

    • Autosomal Dominant Polycystic Kidney Disease •

    NCT01114594

    Pilot Study of RNA as a Biomarker for Autosomal Dominant Polycystic Kidney Disease

    Ages eligible for study: 18 years and older

    Sponsors and collaborators: The Rogosin Institute, Rockefeller University, and Weill Medical College of Cornell University

    Contact: Stephanie Donahue, NP

    Phone: 212-746-1591

    E-mail: sld9001@nyp.org

    Contact: Ines Chicos, CCRC

    Phone: 212-746-3541

    E-mail: inc9012@nyp.org

    Back to Top | Article Outline
    NCT01214421

    Study to Evaluate the Long-Term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects with Autosomal Dominant Polycystic Kidney Disease

    Sponsors and collaborators: Otsuka Pharmaceutical Development & Commercialization Inc.

    Contact: Holly Krasa, MSc

    Phone: 240-683-3270

    E-mail: holly.krasa@otsuka-us.com

    Contact: Laurie Debuque

    Phone: 609-524-6894

    E-mail: laurie.debuque@otsuka-us.com

    Back to Top | Article Outline

    • Chronic Kidney Disease •

    NCT01217281

    The Effect of Nonsurgical Periodontal Treatment in the Renal Function of Patients with Chronic Kidney Disease

    Ages eligible for study: 18 years to 80 years

    Sponsors and collaborators: University of Athens

    Contact: Spyros Kouris, MClinDent

    Phone: 30-210-806899

    E-mail: spkouris@dent.uoa.gr

    Contact: Phoebus N. Madianos, PhD

    Phone: 30-210-7461181

    E-mail: pmadian@dent.uoa.gr

    Back to Top | Article Outline
    NCT01150851

    Oxidative Stress in Chronic Kidney Disease: Diet and Exercise

    Ages eligible for study: 18 years to 75 years

    Sponsors and collaborators: Vanderbilt University and University of Washington

    Contact: Alp Ikizler, MD

    Phone: 615-343-6104

    E-mail: alp.ikizler@vanderbilt.edu

    Contact: Jonathan Himmelfarb, MD

    Phone: 206-744-4933

    E-mail: jhimmelfarb@nephrology.washington.edu

    Back to Top | Article Outline

    • Chronic Kidney Disease– Mineral and Bone Disorder •

    NCT01110629

    Study in Chronic Kidney Disease (CKD) Not on Dialysis

    Ages eligible for study: 20 years and older

    Sponsors and collaborators: Bayer and Shire Pharmaceutical Development

    Contact: Bayer Clinical Trials Contact

    E-mail: clinical-trials-contact@bayerhealthcare.com

    Back to Top | Article Outline
    NCT01136564

    Reno- and Vascular Protective Effect of a Vitamin D Analogue in Moderate to Severe Chronic Kidney Disease

    Ages eligible for study: 18 years and older

    Sponsors and collaborators: Holstebro Hospital

    Contact: Thomas Larsen, MD

    Phone: 45 9912 5425

    E-mail: thomalse@rm.dk

    Contact: Erling B. Pedersen, MD, PhD

    Phone: 45 9912 5704

    E-mail: ebp@dadlnet.dk

    Back to Top | Article Outline
    NCT00752102

    Vitamin D and Coronary Calcification Study

    Ages eligible for study: 25 years and older

    Sponsors and collaborators: University of Pennsylvania and Abbott

    Contact: Philip T. Cochetti

    Phone: 215-615-3848

    E-mail: philip.cochetti@uphs.upenn.edu

    Contact: Christine Bonney

    Phone: 215-615-3848

    E-mail: christine.bonney@uphs.upenn.edu

    Back to Top | Article Outline
    NCT00781417

    Prevention of Secondary Hyperparathyroidism with Vitamin D in Stage II/III ChronicKidney Disease

    Ages eligible for study: 18 years to 85 years

    Sponsors and collaborators: Atlanta VA Medical Center

    Contact: Vin Tangpricha, MD, PhD

    Phone: 404-321-6111, ext 2080

    E-mail: vin.tangpricha@emory.edu

    Back to Top | Article Outline
    NCT00755690

    Study of Dietary Phosphate and Mineral Homeostasis in Early Chronic Kidney Disease

    Ages eligible for study: 19 years and older

    Sponsors and collaborators: University of British Columbia

    Contact: Mhairi Sigrist, MD

    Phone: 604-682-2344, ext 62979

    E-mail: msigrist@providencehealth.bc.ca

    Back to Top | Article Outline
    NCT01020487

    Safety and Efficacy of Paricalcitol Capsules in Decreasing Serum Parathyroid Hormone Levels in Children 10-16 with Chronic Kidney Disease

    Ages eligible for study: 10 years to 16 years

    Sponsors and collaborators: Abbott

    Contact: Kristin Costello

    Phone: 847-938-8107

    E-mail: kristin.costello@abbott.com

    Contact: Samina Khan, MD

    Phone: 824-938-1246

    E-mail: samina.khan@abbott.com •

    © 2010 Lippincott Williams & Wilkins, Inc.